{"id":"NCT00407030","sponsor":"Merz Pharmaceuticals GmbH","briefTitle":"IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia","officialTitle":"Prospective, Double-blind, Placebo-controlled, Randomized, Multi-center Trial With a Double-blind Parallel-group Extension Period to Investigate the Efficacy and Safety of Different Doses of IncobotulinumtoxinA (Xeomin) in the Treatment of Cervical Dystonia","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-07","primaryCompletion":"2008-01","completion":"2009-06","firstPosted":"2006-12-04","resultsPosted":"2010-12-31","lastUpdate":"2013-07-19"},"enrollment":233,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Cervical Dystonia"],"interventions":[{"type":"DRUG","name":"incobotulinumtoxinA (Xeomin) (240 Units)","otherNames":[]},{"type":"DRUG","name":"incobotulinumtoxinA (Xeomin) (120 Units)","otherNames":[]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"incobotulinumtoxinA (Xeomin) (240 Units)","type":"EXPERIMENTAL"},{"label":"incobotulinumtoxinA (Xeomin) (120 Units)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"At baseline patients received incobotulinumtoxinA (Xeomin) or placebo. Thereafter, all patients who entered the extension period were treated with up to five injection sessions of incobotulinumtoxinA (Xeomin) during the extension period.","primaryOutcome":{"measure":"Change From Baseline in the Toronto Western Spasmodic Torticollis Rating Scale (TWSTRS) -Total Score at Week 4 After Injection of the Main Period - Xeomin (240 Units) Versus Placebo","timeFrame":"Baseline, week 4","effectByArm":[{"arm":"incobotulinumtoxinA (Xeomin) (240 Units)","deltaMin":-7.3,"sd":2.18},{"arm":"Placebo","deltaMin":1.6,"sd":2.28}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":9},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["21764407","23779062"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":4,"n":81},"commonTop":["Dysphagia","Neck pain","Muscular weakness","Injection site pain","Musculosceletal pain"]}}